All Stories

  1. Elements of successful NIH grant applications
  2. Overlapping Science in Radiation and Sulfur Mustard Exposures of Skin and Lung: Consideration of Models, Mechanisms, Organ Systems, and Medical Countermeasures
  3. Granulocyte Colony-Stimulating Factor (Neupogen®; Filgrastim) Accelerates Neutrophil Recovery in a Rodent Model of Sulfur Mustard-Induced Hematologic Toxicity
  4. Supporting discovery and development of medical countermeasures for chemical injury to eye and skin
  5. A novel sulfur mustard (HD) vapor inhalation exposure model of pulmonary toxicity for the efficacy evaluation of candidate medical countermeasures
  6. The Kv7 Modulator, Retigabine, is an Efficacious Antiseizure Drug for Delayed Treatment of Organophosphate-induced Status Epilepticus
  7. A Rodent Model of Sulfur Mustard Hematologic Toxicity for the Efficacy Evaluation of Candidate Medical Countermeasures
  8. Ocular Surface – Merging Challenges and Opportunities
  9. Considerations in developing medical countermeasures against chemical ocular toxicity
  10. Abstracts of Presentations from the 2020 Trans-Agency Scientific Meeting on Developing Medical Countermeasures to Treat the Acute and Chronic Effects of Ocular Chemical Toxicity, 25–26 February, Bethesda, Maryland
  11. The National Institutes of Health Chemical Countermeasures Research Program ( NIH CCRP ): A collaborative opportunity to develop effective and accessible chemical medical countermeasures for the American people
  12. Supporting Fundamental Chemical Toxicology Research To Inform Medical Countermeasure Developments: The National Institutes of Health Chemical Countermeasures Research Program
  13. Screening for Efficacious Anticonvulsants and Neuroprotectants in Delayed Treatment Models of Organophosphate-induced Status Epilepticus
  14. National Institutes of Health (NIH) Executive Meeting Summary: Developing Medical Countermeasures to Rescue Opioid-Induced Respiratory Depression (a Trans-Agency Scientific Meeting)—August 6/7, 2019
  15. Evaluating the broad-spectrum efficacy of the acetylcholinesterase oximes reactivators MMB4 DMS, HLö-7 DMS, and 2-PAM Cl against phorate oxon, sarin, and VX in the Hartley guinea pig
  16. Kinetic analysis of oxime-assisted reactivation of human, Guinea pig, and rat acetylcholinesterase inhibited by the organophosphorus pesticide metabolite phorate oxon (PHO)
  17. Efficacy of Recommended Prehospital Human Equivalent Doses of Atropine and Pralidoxime Against the Toxic Effects of Carbamate Poisoning in the Hartley Guinea Pig
  18. Acute toxicity of phorate oxon by oral gavage in the Sprague-Dawley rat
  19. Synthesis and Storage Stability of Diisopropylfluorophosphate
  20. Toxicity and median effective doses of oxime therapies against percutaneous organophosphorus pesticide and nerve agent challenges in the Hartley guinea pig
  21. QuEChERS-based approach toward the analysis of two insecticides, methomyl and aldicarb, in blood and brain tissue
  22. Assessing the therapeutic efficacy of oxime therapies against percutaneous organophosphorus pesticide and nerve agent challenges in the Hartley guinea pig
  23. A novel sulfur mustard (HD) vapor inhalation exposure system for accurate inhaled dose delivery
  24. A comprehensive evaluation of the efficacy of leading oxime therapies in guinea pigs exposed to organophosphorus chemical warfare agents or pesticides
  25. Evaluation of HemogloBind<sup>TM</sup> treatment for preparation of samples for cholinesterase analysis
  26. The CounterACT Research Network: Basic Mechanisms and Practical Applications
  27. Dramatic Differences in Organophosphorus Hydrolase Activity between Human and Chimeric Recombinant Mammalian Paraoxonase-1 Enzymes
  28. Strategies to Enhance Medical Countermeasures After the Use of Chemical Warfare Agents on Civilians
  29. A Gas Chromatographic-Mass Spectrometric Approach to Examining Stereoselective Interaction of Human Plasma Proteins with Soman*
  30. Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: A mini review
  31. Direct detection of stereospecific soman hydrolysis by wild-type human serum paraoxonase
  32. Analysis of active-site amino-acid residues of human serum paraoxonase using competitive substrates
  33. Structure/function analyses of human serum paraoxonase (HuPON1) mutants designed from a DFPase-like homology model